Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Policy Evolution : Government policies regarding coverage, accessibility, and classification of obesity as a disease will substantially impact adoption patterns and market growth
Theres flexibility instead of a one-size-fits-all commitment
Companies are racing to develop alternatives to injectable diabetes and weight loss drugs Injectable peptide drugs targeting the glucagon-like peptide 1 (GLP-1) receptor have had massive impact on approaches to treating diabetes and obesity, bringing huge revenue boosts to makers Novo Nordisk and Eli Lilly
The formula: Volume to add (mL) = Peptide mass (mg) divided by Desired concentration (mg/mL) Example: Fill weight from COA: 5.00 mg Desired working concentration: 2 mg/mL Volume to add: 5.00 divided by 2.00 = 2.50 mL bacteriostatic water Common working concentrations used in CJC-1295 research protocols range from 0.5 mg/mL to 2 mg/mL, depending on experimental design and aliquot volume requirements
US$ 23.79
US$ 20.53
US$ 26.34
US$ 20.79
US$ 23.48
